Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Phase II Dose Optimization with EZH2/EZH1 Inhibitor Tulmimetostat in Patients (pts) with Advanced Solid Tumors or Hematologic Malignancies.

Ana Oaknin,Kalyan Banda,Charles Drescher,Vincent Ribrag,Hedy L. Kindler,Harriet S. Walter,Alok Tewari,Elvire Pons-Tostivint,Nehal J. Lakhani,R. Donald Harvey,Ryan J. Sullivan,Pier Luigi Zinzani,Antonio Gonzalez Martin,Lauriane Eberst,Luis Manso Sanchez,Anjali Thakur, Lennart Kann, Archana Reddy,Nicola Faulhaber,Linda Duska

Journal of Clinical Oncology（2024）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined